Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T54582
|
||||
Former ID |
TTDI02132
|
||||
Target Name |
Nicotinamide phosphoribosyltransferase
|
||||
Gene Name |
NAMPT
|
||||
Synonyms |
NAmPRTase; Nampt; PreB cellenhancing factor; PreBcell colonyenhancing factor 1; Visfatin; NAMPT
|
||||
Target Type |
Clinical Trial
|
||||
Disease | Leukemia [ICD9: 208.9; ICD10: C90-C95] | ||||
Solid tumours [ICD9: 140-199, 210-229; ICD10: C00-D48] | |||||
Function |
Catalyzes the condensation ofnicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation ofclock target gene expression by releasing the core clock component: CLOCK-ARNTL/BMAL1 heterodimer from NAD-dependent SIRT1-mediated suppression (By similarity).
|
||||
BioChemical Class |
Pentosyltransferase
|
||||
UniProt ID | |||||
EC Number |
EC 2.4.2.12
|
||||
Sequence |
MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFY
GLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVP EGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETS GNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGY SVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIV SRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINT LQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVAD PNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNA QLNIELEAAHH |
||||
Drugs and Mode of Action | |||||
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
TEP | EXP Info | ||||
Pathways | |||||
BioCyc Pathway | NAD salvage | ||||
KEGG Pathway | Nicotinate and nicotinamide metabolism | ||||
Metabolic pathways | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
IL1 Signaling Pathway | |||||
TCR Signaling Pathway | |||||
PathWhiz Pathway | Nicotinate and Nicotinamide Metabolism | ||||
Reactome | CLOCK,NPAS2 activates circadian gene expression | ||||
WikiPathways | Adipogenesis | ||||
Metabolism of water-soluble vitamins and cofactors | |||||
Circadian Clock | |||||
References | |||||
Ref 529259 | Anticancer agent CHS-828 inhibits cellular synthesis of NAD. Biochem Biophys Res Commun. 2008 Mar 21;367(4):799-804. | ||||
Ref 529259 | Anticancer agent CHS-828 inhibits cellular synthesis of NAD. Biochem Biophys Res Commun. 2008 Mar 21;367(4):799-804. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.